In the very near future, you may visit your doctor and receive a drug therapy that was customized just for you based on your DNA, metabolism, and lifestyle. Advances in key technologies, including decoding the human genome (DNA), artificial intelligence (AI), and health information, are the catalysts for the rapidly accelerating field of personalized medicine. Navid Alipour, JD (Moderator) Co-founder and Managing Partner, Analytics Ventures Navid Alipour is Co-founder and Managing Partner at Analytics Ventures, a Venture Formation Fund focused on starting new ventures with artificial intelligence and machine learning at their core. Prior to co-founding Analytics Ventures, he founded La Costa Investment Group, making investments in startups nationally. Through the founding of multiple Artificial Intelligence(AI) based companies like CureMetrix and CureMatch, Navid is a long-time entrepreneur in the AI space, and looks to address the need between angel investors and big venture capital funds.